Atossa Therapeutics Files 8-K Report
Ticker: ATOS · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1488039
| Field | Detail |
|---|---|
| Company | Atossa Therapeutics, INC. (ATOS) |
| Form Type | 8-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
Related Tickers: ATOS
TL;DR
ATOS filed an 8-K on 4/7/25 for 'Other Events' - no major news yet.
AI Summary
On April 7, 2025, Atossa Therapeutics, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure, with no specific financial transactions or material agreements detailed in the provided excerpt. The report was filed with the SEC and pertains to the company's ongoing corporate activities.
Why It Matters
This filing signals that Atossa Therapeutics has reported a material event to the SEC, which could be significant for investors monitoring the company's progress and regulatory compliance.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not disclose any immediate financial risks or significant negative developments.
Key Players & Entities
- Atossa Therapeutics, Inc. (company) — Registrant
- April 7, 2025 (date) — Date of Report
- 206.588.0256 (phone_number) — Registrant's Telephone Number
FAQ
What specific 'Other Events' are being reported by Atossa Therapeutics, Inc. in this 8-K filing?
The provided excerpt of the 8-K filing does not detail the specific 'Other Events' being reported; it only indicates that this is the item of disclosure.
When was this 8-K report filed with the SEC?
This 8-K report was filed on April 7, 2025.
What is the exact name of the company filing this report?
The exact name of the company is Atossa Therapeutics, Inc.
What is the principal executive office address for Atossa Therapeutics, Inc.?
The address of the Principal Executive Offices is 10202 5th Avenue NE, Suite 200, Seattle, Washington 98125.
What is the Commission File Number for Atossa Therapeutics, Inc.?
The Commission File Number for Atossa Therapeutics, Inc. is 001-35610.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding ATOSSA THERAPEUTICS, INC. (ATOS).